We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
MDx Market Will Top $4 Billion by 2010, Study Says
News

MDx Market Will Top $4 Billion by 2010, Study Says

MDx Market Will Top $4 Billion by 2010, Study Says
News

MDx Market Will Top $4 Billion by 2010, Study Says

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "MDx Market Will Top $4 Billion by 2010, Study Says "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The MDx market, will grow to $4 billion by the end of the decade, according to a market study announced today by Boston based TSG Partners, a specialty advisory group that combines corporate strategy and corporate finance.

The study covers detection of DNA variation or RNA expression with the intent to diagnose disease, determine a patient’s susceptibility to disease, or determine the prognosis of condition.

The study does not include sample preparation and revenues from contract services and testing performed on open platforms. Identification of bioterrorism agents, predisposition testing, and testing for disease presence and progression such as HPV, other emerging infectious diseases, cancer, and sepsis will drive the market in the next 3-5 years.

While no one can predict the future, diagnostic tests accompanying drugs, the so called “companion diagnostics”, will become more prevalent as pharmaceutical companies move to embrace pharmacogenomics.

Advertisement